Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 489

1.

Prevalence and factors associated with sarcopenia in patients with rheumatoid arthritis.

Torii M, Hashimoto M, Hanai A, Fujii T, Furu M, Ito H, Uozumi R, Hamaguchi M, Terao C, Yamamoto W, Uda M, Nin K, Morita S, Arai H, Mimori T.

Mod Rheumatol. 2018 Aug 9:1-17. doi: 10.1080/14397595.2018.1510565. [Epub ahead of print]

PMID:
30092163
2.

Laminin 511 is a target antigen in autoimmune pancreatitis.

Shiokawa M, Kodama Y, Sekiguchi K, Kuwada T, Tomono T, Kuriyama K, Yamazaki H, Morita T, Marui S, Sogabe Y, Kakiuchi N, Matsumori T, Mima A, Nishikawa Y, Ueda T, Tsuda M, Yamauchi Y, Sakuma Y, Maruno T, Uza N, Tsuruyama T, Mimori T, Seno H, Chiba T.

Sci Transl Med. 2018 Aug 8;10(453). pii: eaaq0997. doi: 10.1126/scitranslmed.aaq0997.

PMID:
30089633
3.

Factors associated with the achievement of biological disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: the ANSWER cohort study.

Hashimoto M, Furu M, Yamamoto W, Fujimura T, Hara R, Katayama M, Ohnishi A, Akashi K, Yoshida S, Nagai K, Son Y, Amuro H, Hirano T, Ebina K, Uozumi R, Ito H, Tanaka M, Ohmura K, Fujii T, Mimori T.

Arthritis Res Ther. 2018 Aug 3;20(1):165. doi: 10.1186/s13075-018-1673-1.

4.

Effectiveness and safety of initiating adalimumab plus ≥12 mg/week methotrexate with adjustable dosing in biologic-naïve patients with early rheumatoid arthritis: HAWK study postmarketing surveillance in Japan.

Tanaka Y, Mimori T, Yamanaka H, Nakajima R, Morita K, Kimura J, Takeuchi T.

Mod Rheumatol. 2018 Jul 14:1-24. doi: 10.1080/14397595.2018.1500979. [Epub ahead of print]

PMID:
30009649
5.

Factors in glucocorticoid regimens associated with treatment response and relapses of IgG4-related disease: a multicentre study.

Shirakashi M, Yoshifuji H, Kodama Y, Chiba T, Yamamoto M, Takahashi H, Uchida K, Okazaki K, Ito T, Kawa S, Yamada K, Kawano M, Hirata S, Tanaka Y, Moriyama M, Nakamura S, Kamisawa T, Matsui S, Tsuboi H, Sumida T, Shibata M, Goto H, Sato Y, Yoshino T, Mimori T.

Sci Rep. 2018 Jul 6;8(1):10262. doi: 10.1038/s41598-018-28405-x.

6.

Non-obese visceral adiposity is associated with the risk of atherosclerosis in Japanese patients with rheumatoid arthritis: a cross-sectional study.

Yoshida T, Hashimoto M, Kawahara R, Yamamoto H, Tanaka M, Ito H, Masuda I, Hosoda K, Yamamoto W, Uozumi R, Morita S, Fujii Y, Mimori T, Nin K.

Rheumatol Int. 2018 Jul 4. doi: 10.1007/s00296-018-4095-0. [Epub ahead of print]

PMID:
29974186
7.

Recurrence of anti-MDA5 antibody-positive clinically amyopathic dermatomyositis after long-term remission: A case report.

Endo Y, Koga T, Ishida M, Fujita Y, Tsuji S, Takatani A, Shimizu T, Sumiyoshi R, Igawa T, Umeda M, Fukui S, Nishino A, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Kuwana M, Hosono Y, Mimori T, Kawakami A.

Medicine (Baltimore). 2018 Jun;97(26):e11024. doi: 10.1097/MD.0000000000011024.

8.

Predictive factors for structural remission using abatacept: Results from the ABROAD study.

Murakami K, Sekiguchi M, Hirata S, Fujii T, Matsui K, Morita S, Ohmura K, Kawahito Y, Nishimoto N, Mimori T, Sano H; ABROAD study investigators.

Mod Rheumatol. 2018 Jun 27:1-7. doi: 10.1080/14397595.2018.1482609. [Epub ahead of print]

PMID:
29807445
9.

[Diagnosis and treatment of rheumatoid arthritis:toward the best practice. The Pathophysiology in Rheumatoid Arthritis.]

Murakami K, Mimori T.

Clin Calcium. 2018;28(5):595-600. doi: CliCa1805595600. Japanese.

PMID:
29731451
10.

Remission induction by Raising the dose of Remicade in RA (RRRR) study: Rationale and study protocol for a randomized controlled trial comparing for sustained clinical remission after discontinuation of infliximab in patients with rheumatoid arthritis.

Oba K, Horie N, Sato N, Saito K, Takeuchi T, Mimori T, Miyasaka N, Koike T, Tanaka Y.

Contemp Clin Trials Commun. 2017 Aug 17;8:49-54. doi: 10.1016/j.conctc.2017.08.007. eCollection 2017 Dec.

11.

Safety and effectiveness of iguratimod in patients with rheumatoid arthritis: Final report of a 52-week, multicenter postmarketing surveillance study.

Mimori T, Harigai M, Atsumi T, Fujii T, Kuwana M, Matsuno H, Momohara S, Takei S, Tamura N, Takasaki Y, Yamamoto K, Ikeuchi S, Kushimoto S, Koike T.

Mod Rheumatol. 2018 Apr 27:1-10. doi: 10.1080/14397595.2018.1460230. [Epub ahead of print]

PMID:
29611761
12.

Factors affecting walking ability in female patients with rheumatoid arthritis.

Morita Y, Ito H, Torii M, Hanai A, Furu M, Hashimoto M, Tanaka M, Azukizawa M, Arai H, Mimori T, Matsuda S.

PLoS One. 2018 Mar 27;13(3):e0195059. doi: 10.1371/journal.pone.0195059. eCollection 2018.

13.

Glucocorticoid receptor expression in resident and hematopoietic cells in IgG4-related disease.

Iguchi T, Takaori K, Mii A, Sato Y, Suzuki Y, Yoshifuji H, Seno H, Ogawa O, Omori K, Bessho K, Kondo S, Yoshizaki T, Nakashima H, Saito T, Mimori T, Haga H, Kawano M, Yanagita M.

Mod Pathol. 2018 Jun;31(6):890-899. doi: 10.1038/s41379-018-0036-4. Epub 2018 Feb 12.

PMID:
29434340
14.

HLA-DRB1 Analysis Identified a Genetically Unique Subset within Rheumatoid Arthritis and Distinct Genetic Background of Rheumatoid Factor Levels from Anticyclic Citrullinated Peptide Antibodies.

Hiwa R, Ikari K, Ohmura K, Nakabo S, Matsuo K, Saji H, Yurugi K, Miura Y, Maekawa T, Taniguchi A, Yamanaka H, Matsuda F, Mimori T, Terao C.

J Rheumatol. 2018 Apr;45(4):470-480. doi: 10.3899/jrheum.170363. Epub 2018 Feb 1.

PMID:
29419463
15.

Clinical practice guideline for Sjögren's syndrome 2017.

Sumida T, Azuma N, Moriyama M, Takahashi H, Asashima H, Honda F, Abe S, Ono Y, Hirota T, Hirata S, Tanaka Y, Shimizu T, Nakamura H, Kawakami A, Sano H, Ogawa Y, Tsubota K, Ryo K, Saito I, Tanaka A, Nakamura S, Takamura E, Tanaka M, Suzuki K, Takeuchi T, Yamakawa N, Mimori T, Ohta A, Nishiyama S, Yoshihara T, Suzuki Y, Kawano M, Tomiita M, Tsuboi H.

Mod Rheumatol. 2018 May;28(3):383-408. doi: 10.1080/14397595.2018.1438093. Epub 2018 Mar 13.

PMID:
29409370
16.

[A case of anti-PL-7 antibody positive polymyositis with thrombotic microangiopathy].

Tamura M, Kitano M, Azuma K, Tsuboi K, Abe T, Ogita C, Yokoyama Y, Furukawa T, Yoshikawa T, Saito A, Nishioka A, Sekiguchi M, Azuma N, Tsunoda S, Hosono Y, Nakashima R, Ohmura K, Matsui K, Mimori T, Sano H.

Nihon Rinsho Meneki Gakkai Kaishi. 2017;40(6):450-455. doi: 10.2177/jsci.40.450. Japanese.

17.

Construction of full-length Japanese reference panel of class I HLA genes with single-molecule, real-time sequencing.

Mimori T, Yasuda J, Kuroki Y, Shibata TF, Katsuoka F, Saito S, Nariai N, Ono A, Nakai-Inagaki N, Misawa K, Tateno K, Kawai Y, Fuse N, Hozawa A, Kuriyama S, Sugawara J, Minegishi N, Suzuki K, Kinoshita K, Nagasaki M, Yamamoto M.

Pharmacogenomics J. 2018 Jan 19. doi: 10.1038/s41397-017-0010-4. [Epub ahead of print]

PMID:
29352165
18.

Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis.

Kochi Y, Kamatani Y, Kondo Y, Suzuki A, Kawakami E, Hiwa R, Momozawa Y, Fujimoto M, Jinnin M, Tanaka Y, Kanda T, Cooper RG, Chinoy H, Rothwell S, Lamb JA, Vencovský J, Mann H, Ohmura K, Myouzen K, Ishigaki K, Nakashima R, Hosono Y, Tsuboi H, Kawasumi H, Iwasaki Y, Kajiyama H, Horita T, Ogawa-Momohara M, Takamura A, Tsunoda S, Shimizu J, Fujio K, Amano H, Mimori A, Kawakami A, Umehara H, Takeuchi T, Sano H, Muro Y, Atsumi T, Mimura T, Kawaguchi Y, Mimori T, Takahashi A, Kubo M, Kohsaka H, Sumida T, Yamamoto K.

Ann Rheum Dis. 2018 Apr;77(4):602-611. doi: 10.1136/annrheumdis-2017-212149. Epub 2018 Jan 13.

PMID:
29331962
19.

Serum soluble interleukin-2 receptor as a biomarker in immunoglobulin G4-related disease.

Handa T, Matsui S, Yoshifuji H, Kodama Y, Yamamoto H, Minamoto S, Waseda Y, Sato Y, Kubo K, Mimori T, Chiba T, Hirai T, Mishima M.

Mod Rheumatol. 2018 Jan 8:1-7. doi: 10.1080/14397595.2017.1416739. [Epub ahead of print]

PMID:
29251035
20.

Andean cutaneous leishmaniasis (Andean-CL, uta) in Peru and Ecuador: the vector Lutzomyia sand flies and reservoir mammals.

Hashiguchi Y, Gomez L EA, Cáceres AG, Velez LN, Villegas NV, Hashiguchi K, Mimori T, Uezato H, Kato H.

Acta Trop. 2018 Feb;178:264-275. doi: 10.1016/j.actatropica.2017.12.008. Epub 2017 Dec 7. Review.

PMID:
29224978
21.

Correlation in the Coronal Angle between Knee and Hindfoot Was Observed in Patients with Rheumatoid Arthritis Unless Talocrural Joint Was Destroyed.

Nishitani K, Ito H, Shimozono Y, Furu M, Azukizawa M, Hashimoto M, Tanaka M, Mimori T, Matsuda S.

Biomed Res Int. 2017;2017:4051706. doi: 10.1155/2017/4051706. Epub 2017 Oct 23.

22.

Factors influencing spinal sagittal balance, bone mineral density, and Oswestry Disability Index outcome measures in patients with rheumatoid arthritis.

Masamoto K, Otsuki B, Fujibayashi S, Shima K, Ito H, Furu M, Hashimoto M, Tanaka M, Lyman S, Yoshitomi H, Tanida S, Mimori T, Matsuda S.

Eur Spine J. 2018 Feb;27(2):406-415. doi: 10.1007/s00586-017-5401-3. Epub 2017 Nov 28.

PMID:
29185111
23.

Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC).

Oku K, Atsumi T, Akiyama Y, Amano H, Azuma N, Bohgaki T, Asanuma YF, Horita T, Hosoya T, Ichinose K, Kato M, Katsumata Y, Kawaguchi Y, Kawakami A, Koga T, Kohsaka H, Kondo Y, Kubo K, Kuwana M, Mimori A, Mimori T, Mimura T, Murakami K, Nakano K, Nakayamada S, Ogishima H, Ohmura K, Saito K, Sano H, Shibuya M, Takahashi Y, Takasaki Y, Takeuchi T, Tamura N, Tanaka Y, Tsuboi H, Tsunoda S, Yukawa N, Yamakawa N, Yamamoto K, Sumida T.

Mod Rheumatol. 2018 Jul;28(4):642-648. doi: 10.1080/14397595.2017.1385154. Epub 2017 Nov 9.

PMID:
29120258
24.

Genetic landscape of interactive effects of HLA-DRB1 alleles on susceptibility to ACPA(+) rheumatoid arthritis and ACPA levels in Japanese population.

Terao C, Okada Y, Ikari K, Kochi Y, Suzuki A, Ohmura K, Matsuo K, Taniguchi A, Kubo M, Raychaudhuri S, Yamamoto K, Yamanaka H, Kamatani Y, Mimori T, Matsuda F.

J Med Genet. 2017 Dec;54(12):853-858. doi: 10.1136/jmedgenet-2017-104779. Epub 2017 Oct 12.

PMID:
29025870
25.

Andean cutaneous leishmaniasis (Andean-CL, uta) in Peru and Ecuador: the causative Leishmania parasites and clinico-epidemiological features.

Hashiguchi Y, Gomez EAL, Cáceres AG, Velez LN, Villegas NV, Hashiguchi K, Mimori T, Uezato H, Kato H.

Acta Trop. 2018 Jan;177:135-145. doi: 10.1016/j.actatropica.2017.09.028. Epub 2017 Oct 7. Review.

PMID:
29017878
26.

Suppressor of TCR signaling-2 (STS-2) suppresses arthritis development in mice.

Okabe N, Ohmura K, Katayama M, Akizuki S, Carpino N, Murakami K, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Tanaka M, Mimori T.

Mod Rheumatol. 2018 Jul;28(4):626-636. doi: 10.1080/14397595.2017.1380249. Epub 2017 Oct 3.

PMID:
28972439
27.

A novel susceptibility locus in the IL12B region is associated with the pathophysiology of Takayasu arteritis through IL-12p40 and IL-12p70 production.

Nakajima T, Yoshifuji H, Shimizu M, Kitagori K, Murakami K, Nakashima R, Imura Y, Tanaka M, Ohmura K, Matsuda F, Terao C, Mimori T.

Arthritis Res Ther. 2017 Sep 6;19(1):197. doi: 10.1186/s13075-017-1408-8.

28.

Anti-centromere antibody exhibits specific distribution levels among anti-nuclear antibodies and may characterize a distinct subset in rheumatoid arthritis.

Kuramoto N, Ohmura K, Ikari K, Yano K, Furu M, Yamakawa N, Hashimoto M, Ito H, Fujii T, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Taniguchi A, Momohara S, Yamanaka H, Matsuda F, Mimori T, Terao C.

Sci Rep. 2017 Jul 31;7(1):6911. doi: 10.1038/s41598-017-07137-4.

29.

Time-averaged disease activity fits better joint destruction in rheumatoid arthritis.

Tsuji H, Yano K, Furu M, Yamakawa N, Ikari K, Hashimoto M, Ito H, Fujii T, Yamamoto W, Ohmura K, Taniguchi A, Momohara S, Matsuda F, Allaart CF, Yamanaka H, Mimori T, Terao C.

Sci Rep. 2017 Jul 19;7(1):5856. doi: 10.1038/s41598-017-05581-w.

30.

Hypoxia-Sensitive COMMD1 Integrates Signaling and Cellular Metabolism in Human Macrophages and Suppresses Osteoclastogenesis.

Murata K, Fang C, Terao C, Giannopoulou EG, Lee YJ, Lee MJ, Mun SH, Bae S, Qiao Y, Yuan R, Furu M, Ito H, Ohmura K, Matsuda S, Mimori T, Matsuda F, Park-Min KH, Ivashkiv LB.

Immunity. 2017 Jul 18;47(1):66-79.e5. doi: 10.1016/j.immuni.2017.06.018.

31.

Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.

Hozumi H, Fujisawa T, Enomoto N, Nakashima R, Enomoto Y, Suzuki Y, Kono M, Karayama M, Furuhashi K, Murakami A, Inui N, Nakamura Y, Mimori T, Suda T.

J Rheumatol. 2017 Sep;44(9):1394-1401. doi: 10.3899/jrheum.170373. Epub 2017 Jul 15.

PMID:
28711881
32.

Myeloperoxidase/HLA Class II Complexes Recognized by Autoantibodies in Microscopic Polyangiitis.

Hiwa R, Ohmura K, Arase N, Jin H, Hirayasu K, Kohyama M, Suenaga T, Saito F, Terao C, Atsumi T, Iwatani H, Mimori T, Arase H.

Arthritis Rheumatol. 2017 Oct;69(10):2069-2080. doi: 10.1002/art.40170. Epub 2017 Aug 25.

PMID:
28575531
33.

Anti-carbamylated Protein Antibodies Are Detectable in Various Connective Tissue Diseases.

Nakabo S, Yoshifuji H, Hashimoto M, Imura Y, Nakashima R, Murakami K, Kuramoto N, Ito S, Satoh J, Tanaka M, Fujii T, Mimori T, Ohmura K.

J Rheumatol. 2017 Sep;44(9):1384-1388. doi: 10.3899/jrheum.161432. Epub 2017 May 15.

PMID:
28507178
34.

The long-term outcome of interstitial lung disease with anti-aminoacyl-tRNA synthetase antibodies.

Tanizawa K, Handa T, Nakashima R, Kubo T, Hosono Y, Watanabe K, Aihara K, Ikezoe K, Sokai A, Nakatsuka Y, Taguchi Y, Hatta K, Noma S, Kobashi Y, Yoshizawa A, Oga T, Hirai T, Chin K, Nagai S, Izumi T, Mimori T, Mishima M.

Respir Med. 2017 Jun;127:57-64. doi: 10.1016/j.rmed.2017.04.007. Epub 2017 Apr 15.

PMID:
28461123
35.

Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies.

Nakabo S, Hashimoto M, Ito S, Furu M, Ito H, Fujii T, Yoshifuji H, Imura Y, Nakashima R, Murakami K, Kuramoto N, Tanaka M, Satoh J, Ishigami A, Morita S, Mimori T, Ohmura K.

Rheumatology (Oxford). 2017 Jul 1;56(7):1217-1226. doi: 10.1093/rheumatology/kex088.

36.

Clinical Images: Chronic Nonbacterial Osteomyelitis.

Takeuchi Y, Murakami K, Kuramoto N, Nakashima R, Hashimoto M, Imura Y, Yoshifuji H, Ohmura K, Mimori T.

Arthritis Rheumatol. 2017 Aug;69(8):1660. doi: 10.1002/art.40108. Epub 2017 Jul 5. No abstract available.

37.

Comparison of performance of the 2016 ACR-EULAR classification criteria for primary Sjögren's syndrome with other sets of criteria in Japanese patients.

Tsuboi H, Hagiwara S, Asashima H, Takahashi H, Hirota T, Noma H, Umehara H, Kawakami A, Nakamura H, Sano H, Tsubota K, Ogawa Y, Takamura E, Saito I, Inoue H, Nakamura S, Moriyama M, Takeuchi T, Tanaka Y, Hirata S, Mimori T, Matsumoto I, Sumida T.

Ann Rheum Dis. 2017 Dec;76(12):1980-1985. doi: 10.1136/annrheumdis-2016-210758. Epub 2017 Mar 22.

38.

Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis.

Terao C, Kawaguchi T, Dieude P, Varga J, Kuwana M, Hudson M, Kawaguchi Y, Matucci-Cerinic M, Ohmura K, Riemekasten G, Kawasaki A, Airo P, Horita T, Oka A, Hachulla E, Yoshifuji H, Caramaschi P, Hunzelmann N, Baron M, Atsumi T, Hassoun P, Torii T, Takahashi M, Tabara Y, Shimizu M, Tochimoto A, Ayuzawa N, Yanagida H, Furukawa H, Tohma S, Hasegawa M, Fujimoto M, Ishikawa O, Yamamoto T, Goto D, Asano Y, Jinnin M, Endo H, Takahashi H, Takehara K, Sato S, Ihn H, Raychaudhuri S, Liao K, Gregersen P, Tsuchiya N, Riccieri V, Melchers I, Valentini G, Cauvet A, Martinez M, Mimori T, Matsuda F, Allanore Y.

Ann Rheum Dis. 2017 Jun;76(6):1150-1158. doi: 10.1136/annrheumdis-2016-210645. Epub 2017 Mar 17. Review.

PMID:
28314753
39.

How to diagnose IgG4-related disease.

Umehara H, Okazaki K, Kawano M, Mimori T, Chiba T.

Ann Rheum Dis. 2017 Nov;76(11):e46. doi: 10.1136/annrheumdis-2017-211330. Epub 2017 Mar 10. No abstract available.

PMID:
28283514
40.

Predictive factors for long-term outcome in polymyositis/dermatomyositis-associated interstitial lung diseases.

Fujisawa T, Hozumi H, Kono M, Enomoto N, Nakamura Y, Inui N, Nakashima R, Imura Y, Mimori T, Suda T.

Respir Investig. 2017 Mar;55(2):130-137. doi: 10.1016/j.resinv.2016.09.006. Epub 2017 Feb 8.

PMID:
28274528
41.

Only rheumatoid factor-positive subset of anti-citrullinated peptide/protein antibody-negative rheumatoid arthritis may seroconvert to anti-citrullinated peptide/protein antibody-positive.

Hiwa R, Ohmura K, Nakabo S, Terao C, Murakami K, Nakashima R, Imura Y, Yukawa N, Yoshifuji H, Hashimoto M, Furu M, Ito H, Fujii T, Mimori T.

Int J Rheum Dis. 2017 Jun;20(6):731-736. doi: 10.1111/1756-185X.13000. Epub 2017 Feb 15.

PMID:
28198158
42.

Current approach to the diagnosis of IgG4-related disease - Combination of comprehensive diagnostic and organ-specific criteria.

Umehara H, Okazaki K, Nakamura T, Satoh-Nakamura T, Nakajima A, Kawano M, Mimori T, Chiba T.

Mod Rheumatol. 2017 May;27(3):381-391. doi: 10.1080/14397595.2017.1290911. Review.

PMID:
28165852
43.

Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.

Enomoto Y, Suzuki Y, Hozumi H, Mori K, Kono M, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suzuki D, Ogawa N, Nakashima R, Mimori T, Iwashita T, Suda T.

Arthritis Res Ther. 2017 Jan 19;19(1):9. doi: 10.1186/s13075-016-1214-8.

44.

A case of anti-aminoacyl tRNA synthetase antibody syndrome complicated by hemophagocytic syndrome.

Azuma K, Tamura M, Kurajoh M, Hosono Y, Nakajima R, Tsuboi K, Abe T, Ogita C, Yokoyama Y, Furukawa T, Yoshikawa T, Saito A, Nishioka A, Sekiguchi M, Azuma N, Kitano M, Tsunoda S, Omura K, Koyama H, Matsui K, Mimori T, Sano H.

Nihon Rinsho Meneki Gakkai Kaishi. 2016;39(6):538-544. doi: 10.2177/jsci.39.538. Review. Japanese.

45.

Association of anti-aminoacyl-transfer RNA synthetase antibody and anti-melanoma differentiation-associated gene 5 antibody with the therapeutic response of polymyositis/dermatomyositis-associated interstitial lung disease.

Yoshida N, Okamoto M, Kaieda S, Fujimoto K, Ebata T, Tajiri M, Nakamura M, Tominaga M, Wakasugi D, Kawayama T, Kuwana M, Mimori T, Ida H, Hoshino T.

Respir Investig. 2017 Jan;55(1):24-32. doi: 10.1016/j.resinv.2016.08.007. Epub 2016 Sep 30.

PMID:
28012490
46.

Cleaved Form of Osteopontin in Urine as a Clinical Marker of Lupus Nephritis.

Kitagori K, Yoshifuji H, Oku T, Sasaki C, Miyata H, Mori KP, Nakajima T, Ohmura K, Kawabata D, Yukawa N, Imura Y, Murakami K, Nakashima R, Usui T, Fujii T, Sakai K, Yanagita M, Hirayama Y, Mimori T.

PLoS One. 2016 Dec 19;11(12):e0167141. doi: 10.1371/journal.pone.0167141. eCollection 2016.

47.

Relationship between handedness and joint involvement in rheumatoid arthritis.

Yaku A, Hashimoto M, Furu M, Ito H, Yamakawa N, Yamamoto W, Fujii T, Matsuda F, Mimori T, Terao C.

Sci Rep. 2016 Dec 15;6:39180. doi: 10.1038/srep39180.

48.

Leishmaniases in Ecuador: Comprehensive review and current status.

Hashiguchi Y, Velez LN, Villegas NV, Mimori T, Gomez EAL, Kato H.

Acta Trop. 2017 Feb;166:299-315. doi: 10.1016/j.actatropica.2016.11.039. Epub 2016 Dec 2. Review.

PMID:
27919688
49.

Splicing factor proline/glutamine-rich is a novel autoantigen of dermatomyositis and associated with anti-melanoma differentiation-associated gene 5 antibody.

Hosono Y, Nakashima R, Serada S, Murakami K, Imura Y, Yoshifuji H, Ohmura K, Naka T, Mimori T.

J Autoimmun. 2017 Feb;77:116-122. doi: 10.1016/j.jaut.2016.11.006. Epub 2016 Dec 3.

PMID:
27919567
50.

Safety and effectiveness of 24-week treatment with iguratimod, a new oral disease-modifying antirheumatic drug, for patients with rheumatoid arthritis: interim analysis of a post-marketing surveillance study of 2679 patients in Japan.

Mimori T, Harigai M, Atsumi T, Fujii T, Kuwana M, Matsuno H, Momohara S, Takei S, Tamura N, Takasaki Y, Ikeuchi S, Kushimoto S, Koike T.

Mod Rheumatol. 2017 Sep;27(5):755-765. doi: 10.1080/14397595.2016.1265695. Epub 2016 Dec 21. Erratum in: Mod Rheumatol. 2017 Sep;27(5):v.

PMID:
27919207

Supplemental Content

Loading ...
Support Center